Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers Wins FDA Approval for Sotyktu for Psoriatic Arthritis
03:30pm, Saturday, 07'th Mar 2026
Bristol Myers won FDA approval for Sotyktu in active psoriatic arthritis, expanding its oral immunology franchise despite a slight after-hours stock dip.
U.S. FDA Approves Bristol Myers Squibb's Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
09:59pm, Friday, 06'th Mar 2026
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #FDA--U.S. FDA Approves Bristol Myers Squibb's Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis.
Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note
06:45pm, Thursday, 05'th Mar 2026
In the latest trading session, Bristol Myers Squibb (BMY) closed at $60.74, marking a -2.55% move from the previous day.
2 Top Healthcare Dividend Stocks to Buy and Hold Forever
03:30pm, Thursday, 05'th Mar 2026
Bristol Myers Squibb can navigate the dreaded patent cliff while maintaining modest dividend growth. Medtronic's strong, innovative business helps support its impressive dividend program.
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
01:55pm, Thursday, 05'th Mar 2026
Reblozyl tops $2.3B in annualized sales, emerging as a key drug for Bristol Myers as demand rises in MDS-related anemia and new study data support expansion.
February Dividends With 4 Raises: 1.6% Up To 14.5%
08:14am, Tuesday, 03'rd Mar 2026
Rose's Income Garden portfolio reached an all-time high, with forward yield dipping slightly to 6% as portfolio value increased. Mastercard stands out with a 14.5% dividend raise, attractive valuation
111 Capital Invests $904,000 in Bristol Myers Squibb Company $BMY
03:03am, Tuesday, 03'rd Mar 2026
111 Capital acquired a new stake in shares of Bristol Myers Squibb Company (NYSE: BMY) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange
Bristol Myers Squibb Announces Dividend
04:16pm, Monday, 02'nd Mar 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend.
BMY Gains 11.4% in a Month: Should You Buy, Sell or Hold the Stock?
01:46pm, Monday, 02'nd Mar 2026
Bristol Myers rides growth brands like Opdivo and Reblozyl to offset generics, with pipeline catalysts and cost cuts shaping its next phase.
Bristol-Myers Squibb Company (BMY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
12:27pm, Monday, 02'nd Mar 2026
Bristol-Myers Squibb Company (BMY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement
11:30pm, Saturday, 28'th Feb 2026
Bristol Myers Squibb is operating in the shadow of the hype surrounding GLP-1 drugs. The company has an attractive and well-supported yield.
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
06:45pm, Friday, 27'th Feb 2026
In the latest trading session, Bristol Myers Squibb (BMY) closed at $62.37, marking a +2.08% move from the previous day.
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Thursday, 26'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Retirees Are Quickly Moving Into These Dividend Funds
09:35am, Thursday, 26'th Feb 2026
Shifting from higher-risk assets to consistent income sources is a natural progression for retirees.
REDMOND, Wash. & PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Patients--SystImmune and BMS Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously-Treat
